The study groups comprised 130 subjects with type 2 diabetes enrolled in the OB-202 / DM-230 Study ( mean baseline HbAc 8.7 % [ 72 mmol/mol ] ) and 388 subjects with type 2 diabetes in the CONQUER Study ( mean baseline HbA1c 6.8 % [ 51 mmol/mol ] ) .